⌘K

Login Start Free

Home/Filings/4/0001062993-25-002181

4//SEC Filing

Heffernan Michael Thomas 4

Accession 0001062993-25-002181

CIK 0001267565other

View on SEC.gov Company Profile

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 4:10 PM ET

Size

4.9 KB

Accession

0001062993-25-002181

Insider Transaction Report

Form 4

Period: 2025-02-10

COLLEGIUM PHARMACEUTICAL, INCCOLL

Heffernan Michael Thomas

Director

Transactions

Award
Common Stock
2025-02-10+4,820→ 50,328 total

Footnotes (1)

[F1]Reflects the grant of fully-vested restricted stock units ("RSUs") granted as compensation for the Reporting Person's service as interim Chief Executive Officer in 2024. Each RSU represents a contingent right to receive one share of the Issuer's common stock.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

COLLEGIUM PHARMACEUTICAL, INC

CIK 0001267565

Entity typeother

Related Parties

1

filerCIK 0001448914

Filing Metadata

Form type: 4
Filed: Feb 11, 7:00 PM ET
Accepted: Feb 12, 4:10 PM ET
Size: 4.9 KB

View on SEC.gov